Skip to main content
Premium Trial:

Request an Annual Quote

Incogen Gets $2M from NCI for Cancer Diagnostic Software Development

NEW YORK, April 19 (GenomeWeb News) - Incogen said today that it has received a $2 million Phase II grant from the National Cancer Institute to develop its cancer diagnostic software.


The company will work with the Collegeof Williamand Mary and the EasternVirginiaMedicalSchoolon the project.


The two-year grant follows on a Phase I grant awarded to Incogen a year ago, which funded the development of a pilot project to analyze proteomics data produced by Ciphergen Biosystems' SELDI platform. In the second phase of the project, Incogen hopes to develop a clinical diagnostic software package for distribution to clinical researchers.


EVMS will produce the data for the project, while W&M and Incogen will analyze the data, the company said.


The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.